Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...
Visionary entrepreneur and health innovator joins the movement to reverse America s chronic disease epidemic WASHINGTON, Apr. 21, 2026 /PRNewswire/ -- MAHA Action, the national organization leading ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Delhi Lieutenant Governor Taranjit Singh Sandhu on Monday said the younger generation has the potential to determine the course of India's progress in fields such as artificial intelligence, ...
The Ministry of Education, on Tuesday, introduced 38 new undergraduate majors that will be available for recruitment through ...
HONG KONG SAR - Media OutReach Newswire - 10 April 2026 - AilsynBio, an AI-driven drug discovery company, held an ...
A Woburn biotechnology company laid off more than 200 Massachusetts employees last week, and state filings warn more cuts may be coming. Replimune Group Inc. spokesperson Arleen Goldenberg confirmed ...
UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, in a deal designed to expand the buyer’s presence in ...
Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including ...
This is a recurring column by Daily Item Creative Director Spenser Hasak, featuring and discussing his favorite photos of the month. Well, we are firmly in spring now, but it certainly doesn’t feel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results